Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 31Carcinoma, Hepatocellular 18Neoplasms 13Neoplasm Metastasis 13Melanoma 13Esophageal Neoplasms 12Nasopharyngeal Carcinoma 10Head and Neck Neoplasms 9Esophageal Squamous Cell Carcinoma 9Colorectal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 8Triple Negative Breast Neoplasms 7Stomach Neoplasms 7Recurrence 7Pancreatic Neoplasms 7Rectal Neoplasms 6Carcinoma, Renal Cell 6Biliary Tract Neoplasms 6Lung Neoplasms 5Small Cell Lung Carcinoma 4Sarcoma 4Ovarian Neoplasms 4Locally Advanced Rectal Cancer 4Colonic Neoplasms 4Advanced NSCLC 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Liver Neoplasms 3Leukemia, Myeloid, Acute 3

Interventions

Diathermy 20Radiotherapy 10Cisplatin 5Fluorouracil 4Drug Therapy 4Radiation 3Melphalan 3Immune Checkpoint Inhibitors 3Cytoreduction Surgical Procedures 3Brachytherapy 3tislelizumab 2Solutions 2Immunotherapy 2Hyperthermia, Induced 2Hydrogen Peroxide 2Doxorubicin 2Conization 2Capecitabine 2spartalizumab 1sodium thiosulfate 1anlotinib 1Temozolomide 1Surgical Procedures, Operative 1Saline Solution 1Radiation Dose Hypofractionation 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Leucovorin 1Laser Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Hyperthermia × Immune Checkpoint Inhibitors × Clear all
NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Zhejiang Hospital

Phase 2 Recruiting
60 enrolled

Hyperthermia

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed
18 enrolled
Gastrointestinal

Hyperthermia, Digestive System Neoplasms

NCT05520853 2022-08-30

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

First People's Hospital of Hangzhou

Phase 2 Unknown
63 enrolled
Thoracic

Hyperthermia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡